H.C. Wainwright Downgrades Avidity Biosciences (RNA) to Neutral Post Novartis Acquisition
Tweet Send to a Friend
H.C. Wainwright analyst Ananda Ghosh downgraded Avidity Biosciences (NASDAQ: RNA) from Buy to Neutral.The analyst comments "What’s New? Avidity Biosciences ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
